News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Talha Badar: Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
Talha Badar/X
May 18, 2025, 11:13

Talha Badar: Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, posted on X:

“Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress, New England Journal of Medicine.
With use of potent BCR: ABL1 directed TKI, long term survival outcome has significantly improved (>75%).
Important question from clinical standpoint : Is chemo-free (blinatumomab) induction with TKI is better than vs chemo +TKI?
Hopefully will be answered by EA9181 study: Testing the Use of Steroids and Tyrosine Kinase Inhibitors with Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults.”

Talha Badar: Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress

More posts featuring Talha Badar.

cancer Lymphoblastic Leukemia New England Journal of Medicine OncoDaily Oncology Talha Badar
Special Coverage
Blog
May 18, 2025, 11:13
Talha Badar: Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
Blog
May 18, 2025, 11:12
Pablo Mando: Honored and Privileged to Have Been Part of the Faculty of BCY at ESMO Breast 2025
Science
May 18, 2025, 10:59
Nina Niu Sanford: FOLFIRINOX vs. Single Agent Gemcitabine in Locally Advanced Pancreas Cancer
Blog
May 18, 2025, 10:58
Jame Abraham: Thank you, Canton Community, for Supporting Women Undergoing Cancer Treatment
Science
May 18, 2025, 10:44
Yan Leyfman: JAMA Study on Cancer Risks from CT Scans
Blog
May 18, 2025, 10:23
Anthony El-Khoueiry: Starting The Los Angeles Cholangiocarcinoma Symposium
Blog
May 18, 2025, 10:14
Drew Moghanaki: HORIZON-01 - ChemoRadiotherapy followed by Alectinib, Entrectinib, or Pralsetinib
Blog
May 18, 2025, 10:01
Martin Zapata Joins Key Voices in Prostate Cancer Discussion
Insight
May 18, 2025, 09:57
Understanding and Prioritizing Cancer Prevention in Women on Women's Health Week – Medicaid Cancer Foundation
Opinion
May 18, 2025, 09:54
Ashraf Saad: Fenretinide Induces Cytotoxicity in GATA1+ Erythroid and Megakaryoblastic Leukemia
Blog
May 18, 2025, 09:44
The Myeloma Minute is Out - International Myeloma Foundation
Blog
May 18, 2025, 09:43
Oncology Brothers: Less than 2 weeks to ASCO25